Drug Type Small molecule drug |
Synonyms Aurisuppostoria Chloramphenicoli, Chloramphenicol (JP17/USP/INN), Chloramphenicol Ear Pills + [31] |
Target |
Action inhibitors |
Mechanism 50S subunit inhibitors(50S ribosomal subunit inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (01 Jun 1951), |
Regulation- |
Molecular FormulaC11H12Cl2N2O5 |
InChIKeyWIIZWVCIJKGZOK-RKDXNWHRSA-N |
CAS Registry56-75-7 |
Start Date20 May 2021 |
Sponsor / Collaborator- |
Start Date15 Nov 2020 |
Sponsor / Collaborator |
Start Date02 Oct 2019 |
Sponsor / Collaborator- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Conjunctivitis, Bacterial | United Kingdom | 13 Dec 1984 | |
Bacterial Vaginosis | Japan | 17 Apr 1981 | |
Bacterial Infections | United States | 01 Jun 1951 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Not Applicable | - | - | Ziclor P gel | ihwtoynehl(pnwcwdlkis) = ATP levels were significantly (p<0.05) reduced by the three formulations exposure compared to the new gel Ziclor P gongglzgom (pfucyivxgu ) View more | - | 01 May 2022 | |
Ducressa eye-drops | |||||||
Not Applicable | - | zhkswkpgcp(goxbwleogk) = hzzchumrzq zhkvungdcx (mtlcifibqs ) | - | 12 Jan 2008 | |||
zhkswkpgcp(goxbwleogk) = gwldurfiiy zhkvungdcx (mtlcifibqs ) |